Professor Peter Schofield was CEO of NeuRA between 2004 and 2022. He is also a Professor of Medicine at UNSW Sydney with extensive professional experience in the biotechnology industry and in medical research institutes in the US, Germany and Australia. At the Garvan Institute he held multiple NHMRC Research Fellowships and was Director of the Neurobiology Program.

His research interests focus on understanding how signalling occurs in the brain, and on identifying genes that lead to psychiatric disorders such as bipolar disorder and on neurodegenerative disorders such as Alzheimers. He has been the site leader of the Sydney site of the NIH-funded Dominantly Inherited Alzheimer Network (DIAN) since the studies inception in 2008. He has published over 400 papers and holds several patents.

He is a Fellow of the Australian Academy of Health and Medical Sciences and has served on many scientific and advocacy bodies, most recently including the NHMRC National Institute of Dementia Research and the Schizophrenia Research Institute. In the 2019 Australia Day Awards he was appointed an Officer of the Order of Australia for distinguished service to medical and scientific research in the field of neuroscience, and to professional institutions.